Carna Biosciences, Inc. (4572.T) JPX

431.00

+16(+3.86%)

Updated at December 25 03:14PM

Currency In JPY

Valuation

Market Cap5.37B
Enterprise Value3.33B
P/E Ratio-3.75
PEG Ratio3.99
Price/Sales Ratio15.09
Price/Book Ratio9.51
Enterprise/Revenue14.24
Enterprise/EBITDA-3.65

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-4.02
Operating Margin-3.77

Management Effectiveness

Return On Assets-1.43
Return On Equity-1.31

Income Statement

Revenue636.24M
Revenue/Share28.49
Gross Profit465.69M
EBITDA-2.14B
Net Income-2.18B
Diluted EPS-121.64

Balance Sheet

Total Cash924.84M
Total Cash/Share48.4
Total Debt464.8M
Total Debt/Equity0.54
Current Ratio9.18
Book Value Per Share45.22

Price History

52-Week Change59.26
52-Week High488
52-Week Low200
Moving Average 50 Days251.96
Moving Average 200 Days268.77

Statistics

Average Volume542,559
Shares Outstanding19.1M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor100:1
Last Split DateDecember 26, 2013